Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisComorbidities and Metabolic Derangement of NAFLDNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentFatty liver disease in diabetes mellitusImmune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsCardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature reviewNonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.Genomic profiling of type-1 adult diabetic and aged normoglycemic mouse liver.Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population.Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cellsInsulin concentration modulates hepatic lipid accumulation in mice in part via transcriptional regulation of fatty acid transport proteins.Prevalence of hepatopathy in type 1 diabetic childrenSystems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.Microbiota and nonalcoholic steatohepatitis.De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular riskDiagnosis and evaluation of nonalcoholic fatty liver disease.Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysisSphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1α Protein ExpressionThe Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease.Multidisciplinary management of patients with cirrhosis: a need for care coordinationLong-term follow-up of hepatic ultrasound findings in subjects with magnetic resonance imaging defined hepatic steatosis following clinical islet transplantation: a case-control studyInhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosisNonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients.Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitusNutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseHepatic transforming growth factor-β 1 stimulated clone-22 D1 controls systemic cholesterol metabolism.Current therapeutic strategies in non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.Therapeutic potential of green tea in nonalcoholic fatty liver disease.Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.Hepatic steatosis in type 1 diabetes.Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.Nonalcoholic fatty liver disease and atherosclerosis.Appraising cardiac dysfunction in liver transplantation: an ongoing challenge.Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
P2860
Q22299426-3E6068C6-822F-4136-901E-A931AF12B4A0Q26775340-4CFB9BAB-613F-4FE1-AD31-85E630EB8324Q26777147-30BC5DB0-E66D-4637-93E9-1D1CA363160AQ26852019-359B23D5-9D2A-46B1-AC4C-B15231F6776FQ26996360-0152E110-AD9A-47B3-87E5-91C1ED66291DQ28079713-BC645CC0-E13A-4563-89A8-3FFBA1225C52Q28081066-86BBCFCC-2269-4437-8612-8B736A97527AQ30622511-2CCE506B-7972-46B9-AA12-19E8B693737DQ33592783-D9937E55-2E16-4533-9236-59BCE0802F61Q33773127-51F16BBA-0D50-462A-BA50-8CB8C1628794Q34088181-46CD4D4A-C14E-4C39-A1A9-1C25BBC61183Q34321195-7FB7F0C1-8515-456B-87A5-A5FD11D421EEQ34435128-E38F49C0-293E-45FC-9CF5-E93A0A759A35Q34467142-E9A077CD-5693-4387-B73F-DD93F24880C6Q35066721-C4438D32-D8AD-400F-9290-F9D4669BF365Q35077618-3C927B1E-07FA-4C0F-B641-0A40F178A3F8Q35171570-E72FC9D5-BDD9-4AC5-A2DC-9B9FC1EFD44CQ35495753-B6ECA607-6638-45C6-A52E-E4D40B44DFD9Q36134867-79B7C9E6-C578-4418-915E-0E11C0DFA30CQ36281733-5A75C7FD-2620-420A-BAB5-14EF9824B410Q36606602-6B434ED2-29E0-4AB4-A404-7FBAAAF58C67Q36816778-DE612C2D-D842-423E-9378-683714C81CAAQ36870361-2EB57474-21B4-40AA-B588-47E306D0094CQ36921054-2659A26D-FE88-44E5-8AF1-94ADCB0A727EQ36937278-47F85439-52DE-484F-9300-BB39FAC521B0Q37192372-CC270620-9859-40AE-988A-A3BE61809F64Q37286751-39EDD5E5-1964-4561-BCCD-7DB16682A4FAQ37488800-95035F03-ACD8-402C-B7BE-784A11AC31B3Q37596189-2CAD9592-0C33-4704-A993-00D9A5AC04F9Q37636425-C125F17E-CD6E-4D6F-B93E-C1EAB34058B2Q37859419-618B9340-525A-4351-953B-2096C9BBAECCQ37873715-AE18A387-057D-43FE-B435-B75496D87655Q37973444-3087B561-1B4D-4A48-A052-29746C417B4CQ38000540-A188BD4C-D57E-4A93-8C1B-66B54809BD82Q38008136-1C8A5175-F69E-4311-8D91-C7FE0720265DQ38009669-E4137E44-62AA-4FF6-B486-5622D1407342Q38016566-BEE1C878-1B69-440D-A417-60F818504057Q38052858-DF32AEF1-CE73-4669-BEC2-72635DAC52F3Q38209496-4F0404CC-2F0C-417E-8456-8BF55C95C82FQ38516786-AD80190B-9042-402D-8311-02A0810F91E2
P2860
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes.
@en
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes.
@nl
type
label
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes.
@en
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes.
@nl
prefLabel
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes.
@en
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes.
@nl
P2093
P921
P1476
Prevalence of non-alcoholic fa ...... patients with type 1 diabetes
@en
P2093
Claudia Sorgato
Giacomo Zoppini
Giovanni Targher
Isabella Pichiri
Lorenzo Bertolini
Luciano Zenari
Roberto Padovani
Stefano Rodella
P304
P356
10.1016/J.JHEP.2010.04.030
P50
P577
2010-06-20T00:00:00Z